![]() | ![]() |
Formats:
|
||||||||||||||||||||||
Copyright Kirienko et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Coordinated Regulation of Intestinal Functions in C. elegans by LIN-35/Rb and SLR-2 Department of Molecular Biology, College of Agriculture, University of Wyoming, Laramie, Wyoming, United States of America Stuart K. Kim, Editor Stanford University Medical Center, United States of America * E-mail: davidfay/at/uwyo.edu Conceived and designed the experiments: NK JM DF. Performed the experiments: NK JM DF. Analyzed the data: NK JM DF. Wrote the paper: NK DF. Received October 18, 2007; Accepted March 24, 2008. This article has been cited by other articles in PMC.Abstract LIN-35 is the sole C. elegans representative of the pocket protein family, which includes the mammalian Retinoblastoma protein pRb and its paralogs p107 and p130. In addition to having a well-established and central role in cell cycle regulation, pocket proteins have been increasingly implicated in the control of critical and diverse developmental and cellular processes. To gain a greater understanding of the roles of pocket proteins during development, we have characterized a synthetic genetic interaction between lin-35 and slr-2, which we show encodes a C2H2-type Zn-finger protein. Whereas animals harboring single mutations in lin-35 or slr-2 are viable and fertile, lin-35; slr-2 double mutants arrest uniformly in early larval development without obvious morphological defects. Using a combination of approaches including transcriptome profiling, mosaic analysis, starvation assays, and expression analysis, we demonstrate that both LIN-35 and SLR-2 act in the intestine to regulate the expression of many genes required for normal nutrient utilization. These findings represent a novel role for pRb family members in the maintenance of organ function. Our studies also shed light on the mechanistic basis of genetic redundancy among transcriptional regulators and suggest that synthetic interactions may result from the synergistic misregulation of one or more common targets. Author Summary Genetic or functional redundancy is a widespread feature of eukaryotic genomes and may be largely attributable to the complex and overlapping nature of many regulatory networks. Despite the prevalence and importance of this phenomenon, the mechanistic bases underlying genetic redundancy have remained elusive, particularly within the context of multicellular developing organisms. To gain a deeper understanding of this phenomenon, we have focused on a synthetic genetic interaction between lin-35, a C. elegans member of the pRb/pocket-protein tumor suppressor family and slr-2, a Zn-finger protein. Whereas single mutants in either lin-35 or slr-2 develop normally, lin-35; slr-2 double mutants display a highly penetrant synthetic growth arrest during early larval development. We show that this arrest is specifically due to an inability to utilize standard nutrient sources. Using a wide range of approaches including transcriptome profiling, mosaic analysis, and expression analysis, we demonstrate that both LIN-35 and SLR-2 act within the intestine to regulate the expression of many genes that function in nutrient utilization. We also show that the basis of the synthetic interaction between lin-35 and slr-2 is not merely due to regulon overlap, but likely results from the synergistic misregulation of multiple shared transcriptional targets in the intestine. Introduction The Retinoblastoma protein, pRb, was among the first recognized tumor suppressor proteins [1]–[3], and loss or repression of pRb function is thought to play a causative role in most human cancers [4]–[8]. The role of pRb as a tumor suppressor has been largely attributed to its functions in cell cycle regulation, which it carries out in conjunction with its two family members, p107 and p130, collectively known as the pocket proteins [9]–[11]. Pocket proteins act primarily as transcriptional repressors and physically associate with diverse array of transcription factors [12]. The most thoroughly characterized of these interactions is with E2F family members, which leads to the repression of E2F-target genes, a group that includes many genes required for entry and progression through S-phase [13]–[16]. Correspondingly, LIN-35, the sole pocket protein ortholog in C. elegans, carries out analogous cell cycle functions during larval stages of development [17]–[21]. In addition, a growing number of studies have demonstrated non−cell cycle roles for pRb family members, which in some cases may prove relevant to the tumor-suppressing activity of pocket proteins [12],[19],[22],[23]. In the case of LIN-35, the majority of these functions are revealed only when LIN-35 activity is compromised in specific mutant backgrounds. This phenomenon can be explained on the basis of genetic or functional redundancy, a widespread feature of eukaryotic genomes, which is attributable to the complex and overlapping nature of many regulatory networks. The first described, and still most thoroughly characterized, genetically redundant function of LIN-35 is its role restricting epidermal cells from inappropriately acquiring vulval cell fates [22],[24],[25]. More specifically, when lin-35, a member of the class B group of synthetic multivulval (SynMuv) genes, is simultaneously inactivated with individual members of the SynMuv A or C classes [24],[26], hyperinduction of vulval cells is observed. In contrast, single mutants in most SynMuv genes, including lin-35, do not display observable defects in vulval development. LIN-35 also redundantly regulates pharyngeal and vulval morphogenesis [27]–[29], asymmetric cell divisions [30], cell fates in the somatic gonad [31], larval growth and development [30],[32],[33], and the promotion of cell death [34]. Furthermore, lin-35 functions non-redundantly in the control of germline gene repression [35] and germline apoptosis [36] and to modulate sensitivity to RNAi [35],[37]. In addition, transcriptome profiling has suggested potential roles for LIN-35 in intestinal and neuronal development, although direct evidence for functions in these tissues has been lacking [21]. Here we describe a novel role for LIN-35 in the intestine of C. elegans. Specifically, we find that LIN-35, in conjunction with the Zn-finger protein SLR-2, acts within intestinal cells to regulate the expression of genes required for proper nutrient utilization. Results lin-35/Rb and slr-2 Are Genetically Redundant A previously described genetic screen was used to identify genes that function redundantly with lin-35 [20]. Briefly, we chemically mutagenized lin-35(n745) mutants that carry an unstable extrachromosomal array (kuEx119), which expresses wild-type lin-35 together with the sur-5::GFP marker. Following F2 clonal selection, we identified strains with synthetic interactions by the presence of visible phenotypes in progeny that failed to inherit the array. One allele, ku297, defines a locus that we have designated as slr-2 (for synthetic with lin-35/Rb). slr-2 single mutants are largely indistinguishable from wild type, although we observed weak-to-moderate elongation defects at low frequencies (the Dpy phenotype). In contrast, lin-35; slr-2 double mutants exhibit uniform early-larval arrest (Figure 1A, 1B
slr-2 Encodes the C2H2 Zinc Finger Y59A8B.13 We mapped ku297 to an ~82-kb region of LGV that contains nine genes, including a predicted C2H2-type Zn-finger protein, Y59A8B.13 (Figure 2A
Using a combination of approaches, we identified a full-length cDNA corresponding to slr-2 that was trans-spliced at the 5′ end to the SL1 spliced leader sequence (Figure S1) [39]. We note that our cDNA-derived sequence for slr-2 differed from WormBase predictions in the location of several exons. That the translation of slr-2 is likely to proceed from the second 5′ ATG is suggested by sequence alignments with the closely related C. briggsae and C. remanei orthologs (Figure 2B Sequencing of the entire slr-2 genomic region in ku297 mutants revealed a single mutation within the splice acceptor site preceding exon six (Figure 2A Transcriptome Analysis of slr-2 Mutants Reveals Functions Associated with the Intestine As our analysis of arrested lin-35; slr-2 larvae failed to reveal any obvious morphological defects, we undertook transcriptome profiling as a means for shedding light the basis of the double-mutant phenotype. Our rationale for this approach stemmed in part from the known roles of LIN-35 and pRb family members in transcriptional control, as well as the presence of four Zn fingers and an acidic domain in SLR-2, which strongly suggest that it too may function as a transcriptional regulator. Thus, we reasoned that the observed genetic redundancy could be due to the misregulation of targets that are common to both regulators. More specifically, we had previously observed two major classes of genes affected in lin-35 mutants at larval stages: cell cycle control and intestinally expressed genes [21]. We therefore hypothesized that SLR-2 may co-regulate genes in either or both of these classes. Because lin-35; slr-2 mutants arrest in early larval development, we focused on the late L1 stage for our microarray analysis. Transcriptome profiling was carried out on three independent biological replicates using Affymetrix GeneChips and established procedures [21]. Our analysis identified ~1,700 genes that are differentially regulated in slr-2(ku297) mutants as compared with identically staged wild-type animals (Figure S2). We further verified expression changes for 29 of these targets by qRT-PCR, thus validating findings from the microarray data (Figure S3 and Table S1). In common with our previous findings for lin-35, the slr-2 data set showed strong overrepresentation of intestine-enriched/intestine-specific genes (p<0.001) as previously identified using a serial analysis of gene expression (SAGE) approach [41]; 261 genes were common to both data sets (Figure 3A
Importantly, lin-35 and slr-2-responsive genes displaying overlap with the SAGE dataset (Figure 3 A previous analysis of intestine-specific/enriched genes identified a single over-represented motif (TGATAA), corresponding to the binding site of the intestinal regulator, ELT-2 [41]. This motif is present in the proximal enhancer regions of 23.3% of genes (using multiple random sampling) in the intestine-specific/enriched dataset used in our above analysis. Using cluster analysis, we independently identified this motif among lin-35 responsive genes [21], and have observed a high frequency of this motif (33–62%) in categories I–IV of overlapping genes from our current analysis (Figure 3A In contrast to intestinal genes, genes with cell cycle functions were not overrepresented in the slr-2 data set (Figure S3). Therefore, the genetic redundancy observed for lin-35 and slr-2 mutants is consistent with their combined effects on intestinal gene misregulation and not to cell cycle defects (also see below). We also note that in addition to intestinal genes, the lin-35 and slr-2 data sets showed upregulation of ~15 common genes with attributed neurological functions. Based on data presented below, it is unlikely, however, that the misregulation of these genes contributes strongly to the double-mutant phenotype. Finally, we observed the downregulation of several dpy genes in slr-2 mutants (dpy-11, dpy-18, and dpy-21), which may account for the variable morphogenetic defects observed in these animals. lin-35 and slr-2 Carry Out Redundant Functions within the Intestine The larval-arrest phenotype of lin-35; slr-2 mutants, along with the results of our transcriptome analysis, are consistent with LIN-35 and SLR-2 acting within the intestine to control the expression of gut-associated genes. To determine the precise tissue focus for LIN-35 and SLR-2, we carried out a mosaic analysis [44]–[47]. This method takes advantage of the inherent mitotic instability of most extrachromosomal arrays and allows for the identification of particular mosaic species, thereby enabling direct correlations to be drawn between gene function and localized expression. To assess the roles of lin-35 and slr-2 in the intestine, we first measured the frequencies by which the C. elegans lin-35 (Ce–lin-35; kuEx119) and C. briggsae slr-2 (Cb–slr-2; fdEx25) rescuing extrachromosomal arrays are spontaneously lost within the intestinal lineage in lin-35 and slr-2 single mutants, respectively. Under these non-selective conditions, intestinal loss was observed in 3.4% and 3.0% of adults carrying the Ce–lin-35 and Cb–slr-2 arrays, respectively (Figure 4H
One limitation to the above analysis is that the absence of intestinal expression in mosaic animals could reflect loss of the array in either the E blastomere (Figure 4D, 4E = 11), which is close to the expected frequency based on the lineage (i.e., the failure to segregate the array during one of three possible cell divisions or 33%). Thus of the total number of kuEx119 intestinal mosaic animals (3.4%), we would expect that 36% had experienced loss specifically within the E-cell lineage. This is equivalent to ~1.2% (or 0.034×0.36) of all animals carrying the Ce–lin-35 array. Thus, if lin-35 is not required within the E-lineage, we would expect to observe ~40 viable intestinal-mosaic adults among the 3,228 lin-35; slr-2 animals assayed. The total absence of intestinal-mosaic adults strongly indicates that lin-35 function is indeed required in the intestine for rescue of lin-35; slr-2 mutants. Correspondingly, E-specific losses accounted for 40% of Cb−slr-2 intestinal mosaic animals (n = 12). Thus, among the 1,254 lin-35; slr-2; fdEx25 animals assayed, ~15 E-specific mosaic animals would have been expected. As for lin-35, the complete absence of intestinal mosaics in the adult population demonstrates that slr-2 activity is also required in the intestine (Figure 4HThe above results conclusively demonstrate that lin-35 and slr-2 are required in the E-cell lineage for rescue of double-mutant lethality. However, these findings do not rule out the possibility that these genes may be simultaneously required in another lineages, such as MS and AB, which are essential for formation of the foregut (Figure 4A = 4) and AB.p (n = 3) lineages, suggesting that neither lin-35 nor slr-2 activity are required within the AB lineage for the rescue of double mutants. Taken together, these results indicate that lin-35 activity is not required in the foregut (or other lineages produced by AB and MS) for rescue of lin-35; slr-2 double-mutants.Previously, we and others have observed a redundant role for lin-35 in the control of intestinal cell proliferation [17],[20]. Given the above indicated intestinal focus of the lin-35; slr-2 phenotype, we examined staged double mutants for abnormalities in intestinal nuclei number and DNA ploidy. We observed wild-type numbers of intestinal nuclei in 54% of lin-35; slr-2 mutants (20±1), although 46% contained 1–14 extra nuclei (Figure S7). This result demonstrates that lin-35; slr-2 mutants undergo larval arrest despite, in most cases, having normal numbers of intestinal nuclei. As a control, we also examined intestinal nuclei numbers in larvae containing a loss-of-function mutation in the APC component, fzr-1, and observed 1–14 extra nuclei in 72% of these animals (Figure S7). Given that only 2% of fzr-1 mutants undergo arrest during larval development (n = 237), this result demonstrates that extra intestinal nuclei per se do not cause larval arrest, a result that is consistent with previous reports [17],[20]. We also failed to detect any difference in DNA ploidy between intestinal cells in wild type and lin-35; slr-2 mutants (Figure S7C-D). Thus, growth arrest in lin-35; slr-2 mutants due to intestinal-associated defects cannot be attributed to overt cell cycle abnormalities.lin-35; slr-2 Mutants Are Defective at Nutrient Utilization The above findings indicate that lin-35; slr-2 double mutants are likely to undergo early larval arrest as a result of intestinal-specific gene misregulation. More precisely, malfunctioning of the intestine in double mutants may lead to nutrient deprivation and subsequent arrested growth. To determine whether lin-35; slr-2 animals are defective at nutrient utilization, we made use of the DAF-16::GFP translational fusion reporter. DAF-16::GFP exhibits diffuse cytoplasmic expression throughout the body in animals that are well fed but rapidly translocates to nuclei following their removal from a food source [48]. Accordingly, in wild type we observed diffuse GFP expression in fed animals at all stages and nuclear localization in populations after nutrient deprivation (Figure 5A, 5D
Because nuclear localization of DAF-16::GFP is known to occur in response to several other forms of environmental stress [48], we performed an independent assay to test whether or not lin-35; slr-2 mutants specifically experience nutritional deprivation. Previous studies have demonstrated that intestinal cell UV-induced autofluorescence, which facilitates the visualization of lysosomal gut granules that serve as sites of fat storage [49], provides a reliable marker for starvation in eating-defective mutants [50]. We therefore examined gut granule autofluorescence in wild-type, lin-35, slr-2, and lin-35; slr-2 staged larvae propagated in the presence or absence of the OP50 food source. Strikingly, by this assay lin-35; slr-2 mutants grown in the presence of food displayed a punctate pattern of gut autofluorescence that was identical to wild-type animals propagated in the absence of the food (Figure 6
Based on our evidence that lin-35; slr-2 larvae have intestinal-associated defects and undergo starvation in the presence of their normal bacterial food source, E. coli (OP50), we hypothesized that suppression of larval arrest might be achievable by supplying double mutants with a preprocessed synthetic food source. To test this, we grew lin-35; slr-2 animals in liquid axenic medium, a nutreint source consisting of peptides, fatty acids, hydrolyzed yeast and soy, dried milk, and hemoglobin [51]. Notably, 19% of double mutants grown in axenic medium were capable of bypassing early larval arrest and 5% of the total population went on to become gravid adults (n = 243). Furthermore, when fertile lin-35; slr-2 adults were placed back onto OP50 plates, progeny from these animals arrested uniformly as L1 larvae. We note that although the observed frequency of suppression of larval arrest was relatively modest in these experiments, the ability of the synthetic medium to bypass what is otherwise a completely penetrant phenotype is highly significant. In addition, we examined the expression pattern of DAF-16::GFP in lin-35; slr-2 mutants rescued from larval arrest by growth on axenic media. Notably, we observed cytosol-specific expression in 95% of rescued double-mutant adults (n = 21; Figure S9). This later finding indicates that the nuclear localization of DAF-16::GFP observed in previous experiments (Figure 5It has previously been shown that developmental arrest resulting from nutrient deprivation is mediated during the L1 stage by a pathway that includes the DAF-18/PTEN lipid phosphatase [52]. One hallmark of this developmental arrest is the cessation of all germ cell proliferation, leading to diminutive gonads. Consistent with lin-35; slr-2 mutants undergoing starvation-induced arrest, gonad size in double mutants was indistinguishable from wild-type starved L1s (Figure S10E). To determine whether or not germline proliferation is inhibited in lin-35; slr-2 mutants by the DAF-18 pathway, we used RNAi feeding to inhibit daf-18 activity in double mutants (See Materials and Methods). Most notably, average gonad size increased by 2.1-fold in double mutants exposed to daf-18(RNAi) (n = 55) versus OP50 controls (n = 59; Figure S10). This result is consistent with our findings indicating that growth arrest in double mutants is due to nutritional deprivation and further demonstrates that the developmental arrest exhibited by lin-35; slr-2 mutants depends, at least in part, on the DAF-18 pathway.Although data presented above, including the mosaic and transcriptome analyses, strongly implicates the intestine as the focus of the lin-35; slr-2 growth-arrested phenotype, defects in bacterial cell uptake and mechanical disruption by the foregut (pharynx) could theoretically account for the starvation-induced arrest. To test for this possibility, we directly assayed the ability of lin-35; slr-2 larvae to ingest a food analog (fluorescent beads) and observed normal uptake in 90% of double mutants at all time points tested (Figure S11). Furthermore, based on a GFP-marked OP50 strain, mechanical disruption of bacteria was completely normal in double mutants twelve hours into larval development, at which time double mutants show strong evidence of starvation-induced growth arrest (Figure S12; Figures 5 slr-2 Is Expressed in the Intestine and Foregut of Developing Larvae Our results indicate that both LIN-35 and SLR-2 function redundantly within the intestine to promote nutrient utilization. Consistent with this, LIN-35 is expressed in many cell types throughout early development including cells of the intestine [25],[53]. To determine the pattern of slr-2 expression during development, we constructed a slr-2::GFP transcriptional reporter using an ~900-bp region upstream of the slr-2 start codon. Based on the location of a nearby adjacent gene, Y59A8B.12 (Figure 2A
slr-2 Interactions with SynMuv Genes As described in the Introduction, lin-35 limits vulval cell induction in cooperation with numerous genes of the SynMuv network. To determine whether or not the observed genetic interaction with slr-2 is specific to lin-35 or is common among other SynMuv family members, we tested seven Class B and one Class A mutant for genetic interactions with slr-2. Interestingly, only one of the tested SynMuv genes, dpl-1, showed strong interactions with slr-2 (Table 1). dpl-1 encodes an ortholog of mammalian DP, which functions as a binding partner for the E2F family of transcriptional regulators. This finding therefore implicates DP and E2F as co-partners of LIN-35 in the transcriptional regulation of intestinal-associated genes. In contrast, the remaining mutants showed at most very weak interactions with slr-2, a finding that underscores the fundamental differences between the role of LIN-35 in vulval cell induction and nutrient utilization (Table 1). To gain mechanistic insight into the observed differences between the interactions of slr-2 with lin-35 and dpl-1, and the non-interacting SynMuv genes, we used qRT-PCR to assay expression levels of 29 genes identified previously by our transcriptome analysis. This included seven genes with intestine-specific expression, ten with known roles in energy production and metabolic regulation, and eight associated with cell cycle, germline, and RNAi functions (Table S2). We first examined expression levels in staged L1 single mutants to determine the frequency of co-regulation between slr-2 and the SynMuv genes. We define co-regulation as the occurrence of a simultaneous increase or decrease in target gene expression levels by ≥1.5 fold relative to wild type. Interestingly, similar levels of co-regulation with slr-2 were observed between the strong interacting (lin-35 and dpl-1) and weak or non-interacting (lin-9 and hpl-2) SynMuv genes tested; lin-35, dpl-1, lin-9, and hpl-2 showed co-regulation of 12, 17, 16, and 17 genes, respectively (Figure 8
To better understand the basis of the observed genetic interactions, we performed qRT-PCR analysis in staged L1 double mutants (also see Materials and Methods). Specifically, we looked for synergistic misregulation effects on co-regulated genes identified by our analysis of single mutants. Genes were scored positive for synergistic effects if the fold change observed in double mutants was ≥1.95-fold higher than the greatest fold-change observed in either single mutant. Thus, for single mutants displaying fold changes of 3.0 and 6.0, a fold change of 11.7 or greater would be defined as synergistic (greater than additive). Notably, we observed synergistic effects on 7/12 and 8/17 lin-35–slr-2 and dpl-1–slr-2 co-regulated targets, respectively (Figure 8 = 0.01 and p<0.001, respectively). These results suggest that the strong synthetic phenotypes observed in lin-35; slr-2 and dpl-1; slr-2 double mutants may be due to the synergistic misregulation of common targets.Discussion We have demonstrated a novel role for the pocket protein ortholog lin-35/Rb in nutrient utilization by the intestine. To our knowledge, these findings constitute the first direct demonstration of a role for pRb family members in the basic maintenance of organ functions. Furthermore, this function is carried out redundantly with SLR-2, a putative transcription factor and previously uncharacterized member of the C. elegans Zn-finger protein family. Multiple lines of evidence support the model that LIN-35 and SLR-2 act within intestinal cells to control the expression of genes required for the proper functioning of the digestive tract. (1) The early growth and developmental arrest of lin-35; slr-2 mutants, coupled with an absence of morphological defects, is consistent with an inability to utilize nutrients (Figure 1 Currently, our data do not distinguish between specific classes of intestinal defects such as those affecting nutrient uptake, processing, or the dissemination of nutrients to other tissues. However, the sizeable number and diverse array of intestinal genes affected in both lin-35 and slr-2 mutants could indicate that multiple, and potentially additive, defects may be involved. We note that foregut-based defects are effectively ruled out as a primary cause of starvation in lin-35; slr-2 mutants based on data from our mosaic analysis as well as additional results indicating that double mutants can both internalize and mechanically disrupt OP50 bacteria (Figures 11–12). A central question posed by our analysis concerns the mechanistic basis of the observed synthetic genetic interaction between lin-35 and slr-2. This question is most directly addressed by our studies of synthetic genetic interactions between slr-2 and nine SynMuv genes (including lin-35), and by our subsequent analysis of transcriptional effects in a subset of both single and double mutants. Somewhat surprisingly, among the 29 genes assayed in single mutants, we found equivalent levels of transcriptional co-regulation between slr-2 and the non-interacting SynMuv genes (hpl-2 and lin-9) and between slr-2 and the strong interactors (lin-35 and dpl-1). This result suggests that regulon overlap alone is not sufficient for the induction of a synthetic genetic interaction (Table 1 and Figure 8 It is also striking that of the seven Slr mutants identified by our laboratory, four (spr-1, xnp-1, psa-1, and slr-2) encode transcriptional regulators [27],[30],[31]. Furthermore, results from other laboratories reveal a strong overrepresentation of transcription factors among genes that display genetic redundancy with lin-35/Rb, including many of the discovered SynMuv genes [22],[25],[33],[34],[55]. Thus, a common theme among lin-35-synthetic interactors appears to be transcriptional regulation. These findings are further consistent with large-scale screens in S. cerevisiae indicating that genetic redundancy is more frequently observed between genes with similar predicted molecular functions [56], and suggests that similar trends will be observed in C. elegans and higher organisms. Our discovery of a role for LIN-35 in promoting nutrient utilization by the intestine also complements several recent reports describing roles for pRb family members in intestinal cell proliferation, morphogenesis, and differentiation. Recently, Haigis and coworkers reported that that simultaneous loss of pRb and either p107 or p130 leads to both structural aberrations and incomplete cellular differentiation in intestinal villi [57]. There are conflicting reports, however, as to whether single mutations in pocket protein members are sufficient to disrupt intestinal development [57]–[59]. Notably, one study using a conditional Rb knockout approach observed dramatic hyperproliferation of intestinal epithelium, leading to villi filling up the luminal space [59]. Consistent with this, we and others have observed pronounced hyperproliferation of intestinal nuclei in double mutants of lin-35 and either fzr-1 [20] or cki-1 [17]. In contrast to the above studies, our current findings uniquely implicate LIN-35 in nutrient acquisition or utilization by the intestine (organ function), and show that this defect is not due to overt cell cycle abnormalities. This latter finding is also consistent with an absence of cell cycle genes from the slr-2 regulon (Figure 3 Our study also further links Zn-finger proteins to pRb-related functions, as a sizeable number of C2H2-type proteins have been shown to physically or genetically interact with pocket protein family members [27], [34], [55], [61]–[66]. In C. elegans, lin-35-interacting Zn-finger transcription factors include lsy-2 and zfp-2, which function coordinately with lin-35 to promote fertility [55]; mcd-1, which acts with lin-35 to promote apoptosis [34]; and spr-4, which redundantly regulates vulval morphogenesis with lin-35 [27]. In addition, the THAP-domain protein GON-14 functions redundantly with LIN-35 to promote larval growth [33], and a mammalian THAP-domain protein, THAP1, acts in parallel to pRb/E2F to control the expression of E2F target genes required for G1–S-phase progression [66]. Thus, interactions between LIN-35 and Zn-finger proteins (frequently C2H2-type proteins) in various organisms have important and versatile roles in development. Materials and Methods Strains and Maintenance C. elegans strains were maintained according to established procedures [67], and all experiments were carried out at 20°C. Strains used in these studies include the following: N2, wild type; MT10430, [lin-35(n745) further backcrossed by our laboratory 5×] [25]; MH1461, [lin-35(n745); kuEx119]; MH1620, [lin-35; slr-2(ku297); kuEx119]; MT1799, [lin-36(n766); unc-32(e189)]; MT5470, [lin-37(n758)]; MT1806, [lin-15A(n767)]; MT2495, [lin-15B(n744)]; MT8840, [dpy-5(e61); lin-53(n833)]; MT8879, [dpl-1(n2994)]; PFR40, [hpl-2(tm1489)]; TJ356, [daf-16::GFP; rol-6]; TY903, [yDf7/unc-76(e911)]; WY53, [lin-35(n745); unc-76(e911); rol-9(sc148)]; WY286, [slr-2(ku297); fdEx25 (CBG05648+sur-5::GFP)]; WY447, [lin-35(n745); slr-2(ku297); fdEx25]; WY471, [lin-35; daf-16::GFP; rol-6]; WY472, [daf-16::GFP; rol-6; slr-2]; WY473, [lin-35; daf-16::GFP; rol-6; slr-2; kuEx119]. slr-2(ku297) Genetic Mapping Genetic mapping of the slr-2(ku297) locus was performed using established procedures [for details see [68]]. Briefly, slr-2 was mapped between unc-76 and rol-9 on LGV. SNP mapping (using the online SNP database at http://genome.wustl.edu/genome/celegans/celegans_snp.cgi) was then used to place the slr-2 locus in an 82.3-kb region defined by SNP:Y59A8B:89830 and SNP:Y59A8B:172162, which contains nine predicted genes. C. briggsae slr-2 Transgenic Rescue The following primers were used to amplify the C. briggsae slr-2 ortholog, CBG05648: 5′-GTGGCATTGTAGGACGATACCC-3′ and 5′-GGAATTCGGAGGGAATTTGAAC-3′. The resulting PCR product, together with the sur-5::RFP marker, was injected into lin-35; slr-2; kuEx119 mutants to generate lines carrying an RFP-marked extrachromosomal array. Rescue was inferred by the ability of the RFP-encoding array to confer viability to worms lacking the GFP-marked lin-35 rescuing array (kuEx119). Seven of seven lines isolated from independently injected P0s yielded strains that could be propagated in the absence of kuEx119. slr-2 Gene Structure 3′ RACE was performed using domains of Y59A8B.13 that are conserved between C. elegans, C. briggsae, and C. remanei. 5′ RACE was performed using a primer complementary to the SL1 trans-splice leader sequence and a primer specific to Y59A8B.13. Microarray, qRT-PCR, and Statistical Analysis RNA was extracted from staged L1 larvae, purified, and used for microarray analysis as previously described [21]. Differentially expressed genes were identified by comparison with identically staged N2 worms using RMA software, as previously described [21]. RNA was extracted from staged L1 larvae, purified, and used for qRT-PCR as previously described [21]. Intestine-specific/enriched genes referenced in our studies were obtained from a previously published SAGE analysis and displayed a minimum intestine:whole worm tag ratio of >2.6 as previously determined [41]. Our P-values were calculated using either t-tests or chi-square tests, where appropriate, using the statistic language R. Pearson correlation coefficients between lin-35 and slr-2 coregulated genes as well as standard errors of mean (or deviation) for all other experiments was calculated using Microsoft Excel. A staged (L1) population of lin-35; slr-2 double mutants (lacking the kuEx119 array) was obtained using a COPAS worm sorter from Union Biometrica. slr-2::GFP A transcriptional reporter was generated by amplifying an ~900-bp region upstream of the slr-2 start codon using the following primers: 5′-CCCATTATCGGCCATTTTTGCTG-3′ and 5′-GGTGCAGGTCGACACTTTTCGACATTTCCGGTGGTCTG-3′. Based on the location of the confirmed gene, Y59A8B.12, which is located <1 kb upstream of the translational start site for slr-2, this sequence is likely to encompass the complete 5′ regulatory region of slr-2. Following digestion with XhoI and SalI, the resulting PCR product was inserted into pPD95.69 (gift of A. Fire), and the obtained plasmid was injected in N2 animals to establish multiple independent extrachromosomal arrays, all of which showed similar patterns of GFP expression. One extrachromosomal array line was then chosen for integration using standard irradiation methods [69]. daf-18(RNAi) RNAi was carried out using standard procedures [70]. MH1620 L4 hermaphrodites were placed on daf-18(RNAi) feeding plates and F1 progeny were assayed 4–5 days later for gonad size. Figure S1 slr-2 cDNA and predicted translated peptide. For additional details, see Materials and Methods and text. (2.49 MB TIF) Click here for additional data file.(2.3M, tif) Figure S2 SLR-2-responsive genes. A complete list of the 1736 genes that showed differential expression in a slr-2 mutant strain. The column labeled “Probesets” refers to Affymetrix probe set numbers, the column referred to as “mountain” refers to gene mountains, described in Kim, et al, 2001. (0.27 MB XLS) Click here for additional data file.(267K, xls) Figure S3 Correlation between microarray and qRT-PCR for slr-2-responcive genes. qRT-PCR and microarray data for slr-2-responsive genes show similar changes in differential expression. Numbers for qRT-PCR represent the mean of at least four samples along with their standard errors. Genes shown in blue include cell cycle, germline, and RNAi-associated genes. (0.34 MB TIF) Click here for additional data file.(334K, tif) Figure S4 SLR-2-responsive genes in an adult SAGE gut library. A complete list of the 261 genes that were differentially expressed in slr-2 mutants as well as present in a SAGE library prepared from the intestine of adult worms (Figure 3 (0.05 MB XLS) Click here for additional data file.(50K, xls) Figure S5 SLR-2-responsive genes differentially expressed in lin-35 mutant worms. A complete list of 261 genes that were differentially expressed in slr-2 mutants as well as in lin-35 mutants (Figure 3 (0.04 MB XLS) Click here for additional data file.(43K, xls) Figure S6 Genes from categories I-IV exhibit strong enrichment in genes associated with intestine and metabolic functions. (A) Overlapping genes from categories I-IV display specific overrepresentation of intestine and metabolic mountains. (B, C) Available expression database results showing that a majority of category I-IV genes exhibit intestinal expression, including many that are intestinal specific. (D) Genes from categories I-IV are enriched for GATA sites relative to the SAGE gut dataset (also see Materials and Methods and Results). (1.67 MB TIF) Click here for additional data file.(1.5M, tif) Figure S7 lin-35; slr-2 cell cycle analysis. (A) Graph showing average intestinal nuclei numbers in wild type (N2), slr-2, lin-35, lin-35; slr-2, and fzr-1 mutants (n = 50 for each strain). Bars indicate standard deviations. Differences observed between lin-35; slr-2 and fzr-1 mutants with wild type were statistically significant (p<0.001). (B) Graph showing distribution of intestinal nuclei numbers in wild-type and mutant strains. Note that whereas only 46% of lin-35; slr-2 double mutants contain greater numbers of intestinal nuclei than wild type, 100% of double mutants arrest. In contrast, whereas 72% of fzr-1 mutants contain extra nuclei, only 2% undergo arrest. DAPI staining of intestinal nuclei in N2 (C) and lin-35; slr-2 double mutants (D). DAPI staining was measured for 25 nuclei (from 8 worms for each genotype) using Openlab software. N2 worms exhibited average fluorescence values of 125% of background and lin-35; slr-2 double mutants exhibited average fluorescence values 127% of background. Arrowheads illustrate intestinal nuclei. Scale bar: 10 µm in panels C and D.(1.34 MB TIF) Click here for additional data file.(1.2M, tif) Figure S8 Intestinal UV autofluorescence in wild-type, lin-35, slr-2, and lin-35; slr-2 double mutant larvae. (A) Panels show representative images (under DAPI channel UV) of intestines from well-fed or starved wild-type, lin-35, slr-2, and lin-35; slr-2 of synchronized larvae. (B) Quantitiation of autofluorescence patterns corresponding to Panel A. Fluorescence was assigned as either punctuate (punct) or diffuse (dif). Note that qualitative differences can be detected between lin-35; slr-2 larvae and other tested strains as early as three hours, though maximal effects are observed by twelve hours. Scale bar: in A, 10 µm for all panels. (8.36 MB TIF) Click here for additional data file.(7.9M, tif) Figure S9 DAF-16::GFP expression in lin-35; slr-2 mutants rescued for arrest by growth on axenic media. DIC (A) and corresponding DAF-16::GFP fluorescence (B) micrographs of a lin-35; slr-2 double mutant rescued from arrest by growth on synthetic axenic media. Note that DAF-16::GFP shows a diffuse cytosolic (non-nuclear) pattern of localization in the intestine, similar to fed wild-type animals. Also see Figure 5 (1.02 MB TIF) Click here for additional data file.(1000K, tif) Figure S10 DAF-18 mediates developmental arrest in lin-35; slr-2 double mutants. DIC micrographs of lin-35; slr-2 double mutants on OP50 (A, B) or daf-18(RNAi) feeding plates (C, D). Animals imaged were the progeny of fertile lin-35(n745); slr-2(ku297); kuEx119 mutants in which the extrachromosomal array had been lost (also see Materials and Methods). Representative gonad sizes (A, C) as well as the largest gonads observed (B, D) for both OP50 and daf-18(RNAi)-treated animals. Gonads are outlined with a yellow dashed line. Scale bar: 10 µm for A-D. (E) Quantification of gonad size in starved WT (N2), lin-35;slr-2 and lin-35;slr-2; daf-18(RNAi) animals. Error bars represent standard deviation. Note that daf-18(RNAi) leads to an ~2-fold increase in the average size of gonads. (4.44 MB TIF) Click here for additional data file.(4.2M, tif) Figure S11 lin-35; slr-2 larvae can internalize food analogs. (A-C) Following synchronization on plates without food, wild-type (N2), lin-35, slr-2, and lin-35; slr-2 double mutants were cultured on plates in the presence (fed) or absence (st) of OP50 bacteria for the times shown (A-C). At the indicated time points, larvae were transferred to plates containing a visually detectable food analog (fluorescent beads, Polyscience, Inc., FluoresbriteTM Polychromatic red microspheres, CAT#19507) for 30 minutes, and bead internalization was then scored by fluorescence microscopy in 50–70 larvae for each time point. Note that at all time points observed, lin-35; slr-2 double mutants did not vary significantly from single mutant controls, nor did fed and starved populations vary significantly from each other. DIC (D, F) and corresponding GFP (E, G) micrographs of wild-type (D, E) and lin-35; slr-2 double mutants (F, G) scored as capable of internalizing beads at 12 hours. Scale bar: 10 µm for panels D-G. (2.12 MB TIF) Click here for additional data file.(2.0M, tif) Figure S12 lin-35; slr-2 larvae can mechanically disrupt bacteria. Following synchronization on plates without food, wild-type (N2) and lin-35; slr-2 larvae were cultured in the absence of food for an additional 3 to 36 hours before placement on plates containing a GFP-marked OP50 bacterial strain. Mechanical disruption is indicated by the presence of GFP-fluorescing bacteria in the foregut only (A). Even after extended periods of time (24–36 hours), the majority of lin-35; slr-2 double mutants were capable of disrupting OP50. Furthermore, mechanical disruption in lin-35; slr-2 larvae was indistinguishable from wild type at 12 hours, where other assays showed clear indications of starvation (also see main text). DIC (B, D) and corresponding GFP (C, E) micrographs of lin-35; slr-2 double mutants that have ingested GFP-marked OP50 bacteria (OP50-GFP strain). Panels B and C depict representative images obtained for the majority of assayed larvae, where GFP fluorescence can be detected only in regions of the alimentary canal that are anterior to the posterior pharyngeal bulb (grinder), where the mechanical disruption of bacteria normally occurs. In a minority of worms at the 24 and 36 hour time points (D and E), some fluorescent bacteria observed in the intestine (arrow). Pharyngeal regions are delineated by yellow braces. Scale bar: 10 µm in panels B-E. (2.16 MB TIF) Click here for additional data file.(2.0M, tif) Figure S13 Expression of slr-2::GFP. DIC (A, C, E) and corresponding GFP (B, D, F) micrographs of an L4 larvae (A, B), a pre-morphogenetic embryo (~300 cell stage; C, D), and late-stage embryo (E, F). Although brightest in the intestinal posterior, reporter expression was observed throughout the intestine in L4 stage larvae. In addition, L4 larvae exhibited expression in marginal cells and the m3VR, mC, I5, m5, m6, and m7 cells of the pharynx, as well as a small subset of head neurons and the excretory duct cell (A, B). Ubiquitous expression was observed in the early embryo (C, D), which becomes largely restricted to the intestine by the pretzel-stage, where expression is brightest in the posterior gut region (E, F). In panels A and B, the posterior region displaying the greatest intense intestinal fluorescence is delineated by a solid white brace and the adjacent dimmer region is delineated by a white, dashed brace. The foregut is delineated by a white dotted dashed brace. In panels E and F, the posterior intestinal region is circled. Scale bar: A, B 100 µm, C-F, 10 µm. (7.21 MB TIF) Click here for additional data file.(6.8M, tif) Table S1 Insulin and TOR signaling networks are down regulated in slr-2 mutants. (0.05 MB DOC) Click here for additional data file.(45K, doc) Table S2 Description of tester genes used for qRT-PCR analysis. (0.05 MB DOC) Click here for additional data file.(51K, doc) Acknowledgments We thank Andy Fire, Eric Hague, James McGhee, and Chris Link for reagents. We thank Tom Johnson and Jim Cypser for the use of their worm sorter. We thank John Yochem, Chris Link, Daniel Hill, Aaron Bender and Amy Fluet for useful input. We especially thank Min Han, in whose lab the ku297 allele was originally isolated. Footnotes The authors have declared that no competing interests exist. This work was supported by NIH grant GM066868-01A1 and ACS grant RSG-03-035-01-DDC. References 1. Dryja TP, Rapaport JM, Joyce JM, Petersen RA. Molecular detection of deletions involving band q14 of chromosome 13 in retinoblastomas. Proc Natl Acad Sci U S A. 1986;83:7391–7394. [PubMed] 2. Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, et al. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 1986;323:643–646. [PubMed] 3. Lee WH, Bookstein R, Hong F, Young LJ, Shew JY, et al. Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science. 1987;235:1394–1399. [PubMed] 4. Bindra RS, Glazer PM. Basal Repression of BRCA1 by Multiple E2Fs and Pocket Proteins at Adjacent E2F Sites. Cancer Biol Ther. 2006;5 5. Knudsen ES, Knudsen KE. Retinoblastoma tumor suppressor: where cancer meets the cell cycle. Exp Biol Med (Maywood). 2006;231:1271–1281. [PubMed] 6. Sherr CJ. Principles of tumor suppression. Cell. 2004;116:235–246. [PubMed] 7. Sherr CJ, McCormick F. The RB and p53 pathways in cancer. Cancer Cell. 2002;2:103–112. [PubMed] 8. Yamasaki L. Role of the RB tumor suppressor in cancer. Cancer Treat Res. 2003;115:209–239. [PubMed] 9. Du W, Pogoriler J. Retinoblastoma family genes. Oncogene. 2006;25:5190–5200. [PubMed] 10. Korenjak M, Brehm A. E2F-Rb complexes regulating transcription of genes important for differentiation and development. Curr Opin Genet Dev. 2005;15:520–527. [PubMed] 11. Stevaux O, Dimova DK, Ji JY, Moon NS, Frolov MV, et al. Retinoblastoma family 2 is required in vivo for the tissue-specific repression of dE2F2 target genes. Cell Cycle. 2005;4:1272–1280. [PubMed] 12. Morris EJ, Dyson NJ. Retinoblastoma protein partners. Adv Cancer Res. 2001;82:1–54. [PubMed] 13. Dannenberg JH, van Rossum A, Schuijff L, te Riele H. Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions. Genes Dev. 2000;14:3051–3064. [PubMed] 14. Du W, Dyson N. The role of RBF in the introduction of G1 regulation during Drosophila embryogenesis. Embo J. 1999;18:916–925. [PubMed] 15. Reed SI. Control of the G1/S transition. Cancer Surv. 1997;29:7–23. [PubMed] 16. Sage J, Mulligan GJ, Attardi LD, Miller A, Chen S, et al. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev. 2000;14:3037–3050. [PubMed] 17. Boxem M, van den Heuvel S. lin-35 Rb and cki-1 Cip/Kip cooperate in developmental regulation of G1 progression in C. elegans. Development. 2001;128:4349–4359. [PubMed] 18. Boxem M, van den Heuvel S. C. elegans class B synthetic multivulva genes act in G(1) regulation. Curr Biol. 2002;12:906–911. [PubMed] 19. Fay DS. The cell cycle and development: lessons from C. elegans. Semin Cell Dev Biol. 2005;16:397–406. [PubMed] 20. Fay DS, Keenan S, Han M. fzr-1 and lin-35/Rb function redundantly to control cell proliferation in C. elegans as revealed by a nonbiased synthetic screen. Genes Dev. 2002;16:503–517. [PubMed] 21. Kirienko NV, Fay DS. Transcriptome profiling of the C. elegans Rb ortholog reveals diverse developmental roles. Dev Biol. 2007;305:674–684. [PubMed] 22. Fay DS, Yochem J. The SynMuv genes of Caenorhabditis elegans in vulval development and beyond. Dev Biol. 2007;306:1–9. [PubMed] 23. Wikenheiser-Brokamp KA. Retinoblastoma family proteins: insights gained through genetic manipulation of mice. Cell Mol Life Sci. 2006;63:767–780. [PubMed] 24. Ferguson EL, Horvitz HR. The multivulva phenotype of certain Caenorhabditis elegans mutants results from defects in two functionally redundant pathways. Genetics. 1989;123:109–121. [PubMed] 25. Lu X, Horvitz HR. lin-35 and lin-53, two genes that antagonize a C. elegans Ras pathway, encode proteins similar to Rb and its binding protein RbAp48. Cell. 1998;95:981–991. [PubMed] 26. Ceol CJ, Horvitz HR. A new class of C. elegans synMuv genes implicates a Tip60/NuA4-like HAT complex as a negative regulator of Ras signaling. Dev Cell. 2004;6:563–576. [PubMed] 27. Bender AM, Kirienko NV, Olson SK, Esko JD, Fay DS. lin-35/Rb and the CoREST ortholog spr-1 coordinately regulate vulval morphogenesis and gonad development in C. elegans. Dev Biol. 2007;302:448–462. [PubMed] 28. Fay DS, Large E, Han M, Darland M. lin-35/Rb and ubc-18, an E2 ubiquitin-conjugating enzyme, function redundantly to control pharyngeal morphogenesis in C. elegans. Development. 2003;130:3319–3330. [PubMed] 29. Fay DS, Qiu X, Large E, Smith CP, Mango S, et al. The coordinate regulation of pharyngeal development in C. elegans by lin-35/Rb, pha-1, and ubc-18. Dev Biol. 2004;271:11–25. [PubMed] 30. Cui M, Fay DS, Han M. lin-35/Rb cooperates with the SWI/SNF complex to control Caenorhabditis elegans larval development. Genetics. 2004;167:1177–1185. [PubMed] 31. Bender AM, Wells O, Fay DS. lin-35/Rb and xnp-1/ATR-X function redundantly to control somatic gonad development in C. elegans. Dev Biol. 2004;273:335–349. [PubMed] 32. Cardoso C, Couillault C, Mignon-Ravix C, Millet A, Ewbank JJ, et al. XNP-1/ATR-X acts with RB, HP1 and the NuRD complex during larval development in C. elegans. Dev Biol. 2005;278:49–59. [PubMed] 33. Chesney MA, Kidd AR, 3rd, Kimble J. gon-14 functions with class B and class C synthetic multivulva genes to control larval growth in Caenorhabditis elegans. Genetics. 2006;172:915–928. [PubMed] 34. Reddien PW, Andersen EC, Huang MC, Horvitz HR. DPL-1 DP, LIN-35 Rb and EFL-1 E2F act with the MCD-1 zinc-finger protein to promote programmed cell death in Caenorhabditis elegans. Genetics. 2007;175:1719–1733. [PubMed] 35. Wang D, Kennedy S, Conte D, Jr, Kim JK, Gabel HW, et al. Somatic misexpression of germline P granules and enhanced RNA interference in retinoblastoma pathway mutants. Nature. 2005;436:593–597. [PubMed] 36. Schertel C, Conradt B. C. elegans orthologs of components of the RB tumor suppressor complex have distinct pro-apoptotic functions. Development. 2007;134:3691–3701. [PubMed] 37. Lehner B, Calixto A, Crombie C, Tischler J, Fortunato A, et al. Loss of LIN-35, the Caenorhabditis elegans ortholog of the tumor suppressor p105Rb, results in enhanced RNA interference. Genome Biol. 2006;7:R4. [PubMed] 38. Maduro M, Pilgrim D. Conservation of function and expression of unc-119 from two Caenorhabditis species despite divergence of non-coding DNA. Gene. 1996;183:77–85. [PubMed] 39. Krause M, Hirsh D. A trans-spliced leader sequence on actin mRNA in C. elegans. Cell. 1987;49:753–761. [PubMed] 40. Blumenthal T, Steward K. RNA processing and gene structure. C elegans II. 1997 41. McGhee JD, Sleumer MC, Bilenky M, Wong K, McKay SJ, et al. The ELT-2 GATA-factor and the global regulation of transcription in the C. elegans intestine. Dev Biol. 2006 42. Kim SK, Lund J, Kiraly M, Duke K, Jiang M, et al. A gene expression map for Caenorhabditis elegans. Science. 2001;293:2087–2092. [PubMed] 43. Hu PJ. Dauer. 2007 WormBook (The C elegans Research Community, Ed) http://www.wormbookorg/ 44. Hedgecock EM, Herman RK. The ncl-1 gene and genetic mosaics of Caenorhabditis elegans. Genetics. 1995;141:989–1006. [PubMed] 45. Yochem J. Nomarski images for learning the anatomy, with tips for mosaic analysis. 2006 WormBook (The C elegans Research Community, Ed) http://www.wormbookorg/ 46. Yochem J, Gu T, Han M. A new marker for mosaic analysis in Caenorhabditis elegans indicates a fusion between hyp6 and hyp7, two major components of the hypodermis. Genetics. 1998;149:1323–1334. [PubMed] 47. Yochem J, Sundaram M, Bucher EA. Mosaic analysis in Caenorhabditis elegans. Methods Mol Biol. 2000;135:447–462. [PubMed] 48. Henderson ST, Johnson TE. daf-16 integrates developmental and environmental inputs to mediate aging in the nematode Caenorhabditis elegans. Curr Biol. 2001;11:1975–1980. [PubMed] 49. Schroeder LK, Kremer S, Kramer MJ, Currie E, Kwan E, et al. Function of the Caenorhabditis elegans ABC transporter PGP-2 in the biogenesis of a lysosome-related fat storage organelle. Mol Biol Cell. 2007;18:995–1008. [PubMed] 50. Shibata Y, Fujii T, Dent JA, Fujisawa H, Takagi S. EAT-20, a novel transmembrane protein with EGF motifs, is required for efficient feeding in Caenorhabditis elegans. Genetics. 2000;154:635–646. [PubMed] 51. Houthoofd K, Braeckman BP, Lenaerts I, Brys K, De Vreese A, et al. Axenic growth up-regulates mass-specific metabolic rate, stress resistance, and extends life span in Caenorhabditis elegans. Exp Gerontol. 2002;37:1371–1378. [PubMed] 52. Fukuyama M, Rougvie AE, Rothman JH. C. elegans DAF-18/PTEN mediates nutrient-dependent arrest of cell cycle and growth in the germline. Curr Biol. 2006;16:773–779. [PubMed] 53. Myers TR, Greenwald I. lin-35 Rb acts in the major hypodermis to oppose ras-mediated vulval induction in C. elegans. Dev Cell. 2005;8:117–123. [PubMed] 54. Cui M, Chen J, Myers TR, Hwang BJ, Sternberg PW, et al. SynMuv genes redundantly inhibit lin-3/EGF expression to prevent inappropriate vulval induction in C. elegans. Dev Cell. 2006;10:667–672. [PubMed] 55. Ceron J, Rual JF, Chandra A, Dupuy D, Vidal M, et al. Large-scale RNAi screens identify novel genes that interact with the C. elegans retinoblastoma pathway as well as splicing-related components with synMuv B activity. BMC Dev Biol. 2007;7:30. [PubMed] 56. Tong AH, Lesage G, Bader GD, Ding H, Xu H, et al. Global mapping of the yeast genetic interaction network. Science. 2004;303:808–813. [PubMed] 57. Haigis K, Sage J, Glickman J, Shafer S, Jacks T. The related retinoblastoma (pRb) and p130 proteins cooperate to regulate homeostasis in the intestinal epithelium. J Biol Chem. 2006;281:638–647. [PubMed] 58. Kucherlapati MH, Nguyen AA, Bronson RT, Kucherlapati RS. Inactivation of conditional Rb by Villin-Cre leads to aggressive tumors outside the gastrointestinal tract. Cancer Res. 2006;66:3576–3583. [PubMed] 59. Yang HS, Hinds PW. pRb-mediated control of epithelial cell proliferation and Indian hedgehog expression in mouse intestinal development. BMC Dev Biol. 2007;7:6. [PubMed] 60. Martucciello G, Lombardi L, Savasta S, Gibbons RJ. Gastrointestinal phenotype of ATR-X syndrome. Am J Med Genet A. 2006;140:1172–1176. [PubMed] 61. Buyse IM, Shao G, Huang S. The retinoblastoma protein binds to RIZ, a zinc-finger protein that shares an epitope with the adenovirus E1A protein. Proc Natl Acad Sci U S A. 1995;92:4467–4471. [PubMed] 62. Cloos PA, Christensen J, Agger K, Maiolica A, Rappsilber J, et al. The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3. Nature. 2006;442:307–311. [PubMed] 63. Edmonds C, Vousden KH. A point mutational analysis of human papillomavirus type 16 E7 protein. J Virol. 1989;63:2650–2656. [PubMed] 64. He L, Yu JX, Liu L, Buyse IM, Wang MS, et al. RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis. Cancer Res. 1998;58:4238–4244. [PubMed] 65. Huang S, Shao G, Liu L. The PR domain of the Rb-binding zinc finger protein RIZ1 is a protein binding interface and is related to the SET domain functioning in chromatin-mediated gene expression. J Biol Chem. 1998;273:15933–15939. [PubMed] 66. Cayrol C, Lacroix C, Mathe C, Ecochard V, Ceribelli M, et al. The THAP-zinc finger protein THAP1 regulates endothelial cell proliferation through modulation of pRB/E2F cell-cycle target genes. Blood. 2007;109:584–594. [PubMed] 67. Stiernagle T. 2006 Maintenance of C. elegans WormBook (The C elegans Research Community, Ed) http://www.wormbookorg/ 68. Fay DS. Genetic Mapping and Manipulation. 2006 WormBook (The C elegans Research Community, Ed) http://www.wormbookorg/ 69. Mello CC, Kramer JM, Stinchcomb D, Ambros V. Efficient gene transfer in C.elegans: extrachromosomal maintenance and integration of transforming sequences. Embo J. 1991;10:3959–3970. [PubMed] 70. Ahringer J. Reverse Genetics. 2005 WormBook (The C elegans Research Community, Ed) http://www.wormbookorg/ |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||
Proc Natl Acad Sci U S A. 1986 Oct; 83(19):7391-4.
[Proc Natl Acad Sci U S A. 1986]Science. 1987 Mar 13; 235(4794):1394-9.
[Science. 1987]Cancer Treat Res. 2003; 115():209-39.
[Cancer Treat Res. 2003]Oncogene. 2006 Aug 28; 25(38):5190-200.
[Oncogene. 2006]Cell Cycle. 2005 Sep; 4(9):1272-80.
[Cell Cycle. 2005]Adv Cancer Res. 2001; 82():1-54.
[Adv Cancer Res. 2001]Semin Cell Dev Biol. 2005 Jun; 16(3):397-406.
[Semin Cell Dev Biol. 2005]Dev Biol. 2007 Jun 1; 306(1):1-9.
[Dev Biol. 2007]Cell Mol Life Sci. 2006 Apr; 63(7-8):767-80.
[Cell Mol Life Sci. 2006]Genetics. 1989 Sep; 123(1):109-21.
[Genetics. 1989]Dev Biol. 2007 Feb 15; 302(2):448-62.
[Dev Biol. 2007]Dev Biol. 2004 Jul 1; 271(1):11-25.
[Dev Biol. 2004]Genetics. 2004 Jul; 167(3):1177-85.
[Genetics. 2004]Dev Biol. 2004 Sep 15; 273(2):335-49.
[Dev Biol. 2004]Dev Biol. 2005 Feb 1; 278(1):49-59.
[Dev Biol. 2005]Genes Dev. 2002 Feb 15; 16(4):503-17.
[Genes Dev. 2002]Gene. 1996 Dec 12; 183(1-2):77-85.
[Gene. 1996]Cell. 1987 Jun 19; 49(6):753-61.
[Cell. 1987]Dev Biol. 2007 May 15; 305(2):674-84.
[Dev Biol. 2007]Dev Biol. 2007 May 15; 305(2):674-84.
[Dev Biol. 2007]Dev Biol. 2007 May 15; 305(2):674-84.
[Dev Biol. 2007]Science. 2001 Sep 14; 293(5537):2087-92.
[Science. 2001]Dev Biol. 2007 May 15; 305(2):674-84.
[Dev Biol. 2007]Genetics. 1995 Nov; 141(3):989-1006.
[Genetics. 1995]Methods Mol Biol. 2000; 135():447-62.
[Methods Mol Biol. 2000]Development. 2001 Nov; 128(21):4349-59.
[Development. 2001]Genes Dev. 2002 Feb 15; 16(4):503-17.
[Genes Dev. 2002]Curr Biol. 2001 Dec 11; 11(24):1975-80.
[Curr Biol. 2001]Curr Biol. 2001 Dec 11; 11(24):1975-80.
[Curr Biol. 2001]Mol Biol Cell. 2007 Mar; 18(3):995-1008.
[Mol Biol Cell. 2007]Genetics. 2000 Feb; 154(2):635-46.
[Genetics. 2000]Exp Gerontol. 2002 Dec; 37(12):1371-8.
[Exp Gerontol. 2002]Curr Biol. 2006 Apr 18; 16(8):773-9.
[Curr Biol. 2006]Cell. 1998 Dec 23; 95(7):981-91.
[Cell. 1998]Dev Cell. 2005 Jan; 8(1):117-23.
[Dev Cell. 2005]Dev Cell. 2006 May; 10(5):667-72.
[Dev Cell. 2006]Dev Biol. 2007 Feb 15; 302(2):448-62.
[Dev Biol. 2007]Genetics. 2004 Jul; 167(3):1177-85.
[Genetics. 2004]Dev Biol. 2004 Sep 15; 273(2):335-49.
[Dev Biol. 2004]Dev Biol. 2007 Jun 1; 306(1):1-9.
[Dev Biol. 2007]Cell. 1998 Dec 23; 95(7):981-91.
[Cell. 1998]J Biol Chem. 2006 Jan 6; 281(1):638-47.
[J Biol Chem. 2006]BMC Dev Biol. 2007 Jan 26; 7():6.
[BMC Dev Biol. 2007]Genes Dev. 2002 Feb 15; 16(4):503-17.
[Genes Dev. 2002]Development. 2001 Nov; 128(21):4349-59.
[Development. 2001]Am J Med Genet A. 2006 Jun 1; 140(11):1172-6.
[Am J Med Genet A. 2006]Dev Biol. 2007 Feb 15; 302(2):448-62.
[Dev Biol. 2007]Genetics. 2007 Apr; 175(4):1719-33.
[Genetics. 2007]BMC Dev Biol. 2007 Apr 6; 7():30.
[BMC Dev Biol. 2007]Proc Natl Acad Sci U S A. 1995 May 9; 92(10):4467-71.
[Proc Natl Acad Sci U S A. 1995]Blood. 2007 Jan 15; 109(2):584-94.
[Blood. 2007]Cell. 1998 Dec 23; 95(7):981-91.
[Cell. 1998]Dev Biol. 2007 May 15; 305(2):674-84.
[Dev Biol. 2007]EMBO J. 1991 Dec; 10(12):3959-70.
[EMBO J. 1991]